EPHA2 and non-small cell lung carcinoma: The presented data is furthermore in line with earlier reports in NSCLC upon IR treatment [52] and illustrates that IR alongside EGFR- or VEGFR2 targeted therapy may influence EphA2 phosphorylation status on S897 [27,28,34].